Bullous Pemphigoid and Dipeptidyl Peptidase 4 Inhibitors: A Disproportionality Analysis Based on the Japanese Adverse Drug Event Report Database

被引:64
作者
Arai, Masanori [1 ]
Shirakawa, Jun [1 ]
Konishi, Hiromi [1 ]
Sagawa, Naoko [1 ]
Terauchi, Yasuo [1 ]
机构
[1] Yokohama City Univ, Grad Sch Med, Dept Endocrinol & Metab, Yokohama, Kanagawa, Japan
关键词
PHARMACOVIGILANCE DATABASE; IV INHIBITORS;
D O I
10.2337/dc18-0210
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E130 / E132
页数:3
相关论文
共 5 条
[1]   Bullous pemphigoid and dipeptidyl peptidase IV inhibitors: a case-noncase study in the French Pharmacovigilance Database [J].
Bene, J. ;
Moulis, G. ;
Bennani, I. ;
Auffret, M. ;
Coupe, P. ;
Babai, S. ;
Hillaire-Buys, D. ;
Micallef, J. ;
Gautier, S. .
BRITISH JOURNAL OF DERMATOLOGY, 2016, 175 (02) :296-301
[2]   Dipeptidyl peptidase-IV inhibitors induced bullous pemphigoid: a case report and analysis of cases reported in the European pharmacovigilance database [J].
Garcia, M. ;
Aranburu, M. A. ;
Palacios-Zabalza, I. ;
Lertxundi, U. ;
Aguirre, C. .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2016, 41 (03) :368-370
[3]  
Pasmatzi Efi, 2011, Diabetes Care, V34, pe133, DOI 10.2337/dc11-0804
[4]   The reporting odds ratio and its advantages over the proportional reporting ratio [J].
Rothman, KJ ;
Lanes, S ;
Sacks, ST .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2004, 13 (08) :519-523
[5]   Drug-induced pemphigoid: a review of the literature [J].
Stavropoulos, P. G. ;
Soura, E. ;
Antoniou, C. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2014, 28 (09) :1133-1140